References
- ISHLT: The International Society for Heart & Lung Transplantation [Internet]; 2017. [cited 2017 Jun 6]. Available from: https://www.ishlt.org/registries/slides.asp?slides=heartLungRegistry
- Christie JD, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–1459.
- Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med. 2011;32:279–293.
- Ailawadi G, Lau CL, Smith PW, et al. Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg. 2009;137:688–694.
- Kreisel D, Krupnick AS, Puri V, et al. Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg. 2011;141:215–222.
- Whitson BA, Prekker ME, Herrington CS, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant. 2007;26:1004–1011.
- Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007;175:507–513.
- Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73:1041–1048.
- Kosieradzki M, Rowiński W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc. 2008;40:3279–3288.
- de Perrot M, Liu M, Waddell TK, et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167:490–511.
- Salahudeen AK. Cold ischemic injury of transplanted kidneys: new insights from experimental studies. Am J Physiol Renal Physiol. 2004;287:F181–F187.
- Jayle C, Favreau F, Zhang K, et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol. 2007;292:F1082–F1093.
- Thuillier R, Dutheil D, Trieu MTN, et al. Supplementation With a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation: a new O2 therapeutic molecule improves static kidney preservation. Am J Transplant. 2011;11:1845–1860.
- Mallet V, Dutheil D, Polard V, et al. Dose-ranging study of the performance of the natural oxygen transporter HEMO2life® in organ preservation. Artif Organs. 2014;38:691–701.
- Rousselot M, Delpy E, Drieu La Rochelle CL, et al. Arenicola marina extracellular hemoglobin: a new promising blood substitute. Biotechnol J. 2006;1:333–345.
- Rousselot M, Le Guen D, Chabasse C, et al. Novel dissociation mechanism of a polychaetous annelid extracellular haemoglobin. FEBS J. 2006;273:1582–1596.
- Zal F, Green BN, Lallier FH, et al. Quaternary structure of the extracellular haemoglobin of the lugworm Arenicola marina: a multi-angle-laser-light-scattering and electrospray-ionisation-mass-spectrometry analysis. Eur J Biochem. 1997;243:85–92.
- Lama VN, Belperio JA, Christie JD, et al. Models of lung transplant research: a consensus statement from the National Heart, Lung, and Blood Institute workshop. JCI Insight. 2017;2(9):93121.
- Trebbia G, Sage E, Fadel E, et al. Ex vivo assessment of extravascular lung water with transpumonary thermodilution. J Heart Lung Transplant. 2013;32:840–842.
- Pizanis N, Petrov A, Heckmann J, et al. A new preservation solution for lung transplantation: evaluation in a porcine transplantation model. J Heart Lung Transplant. 2012;31:310–317.
- Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45:673–676.
- Hosgood SA, Nicholson HFL, Nicholson ML. Oxygenated kidney preservation techniques. Transplantation. 2012;93:455–459.
- Favreau F, Thuillier R, Cau J, et al. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant off J Am Soc Transplant Am Soc Transpl Surg. 2010;10:30–39.
- Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol JASN. 2009;20:2412–2425.
- Maathuis M-HJ, Leuvenink HGD, Ploeg RJ. Perspectives in organ preservation. Transplantation. 2007;83:1289–1298.
- Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation. 2002;74:1804–1809.
- Kuroda Y, Kawamura T, Suzuki Y, et al. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation. 1988;46:457–460.
- Kakehata J, Yamaguchi T, Togashi H, et al. Therapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. J Pharmacol Sci. 2010;114:189–197.
- Spahn DR, Kocian R. Artificial O2 carriers: status in 2005. Curr Pharm Des. 2005;11:4099–4114.
- Regner KR, Nilakantan V, Ryan RP, et al. Protective effect of Lifor solution in experimental renal ischemia-reperfusion injury. J Surg Res. 2010;164:e291–e297.
- Farrar D, Grocott M. Intravenous artificial oxygen carriers. Hosp Med. 2003;64:352–356.
- Tsai AG, Intaglietta M, Sakai H, et al. Microcirculation and NO-CO studies of a natural extracellular hemoglobin developed for an oxygen therapeutic carrier. Curr Drug Discov Technol. 2012;9:166–172.
- Fukuse T, Hirata T, Ishikawa S, et al. Optimal alveolar oxygen concentration for cold storage of the lung. Transplantation. 2001;72:300–304.
- Bacha EA, Hervé P, Murakami S, et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg. 1996;112:590–598.
- Sommer S, Warnecke G, Hohlfeld J, et al. Pulmonary preservation with LPD and celsior solution in porcine lung transplantation after 24 h of cold ischemia. Eur J Cardiothorac Surg. 2004;l26:151–157.
- Inci I, Erne B, Arni S, et al. Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. J Heart Lung Transplant off Publ Int Soc Heart Transplant. 2010;29:1293–1301.
- LaPar DJ, Laubach VE, Emaminia A, et al. Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg. 2011;142:887–894.
- Shaver CM, Ware LB. Primary graft dysfunction: pathophysiology to guide new preventive therapies. Expert Rev Respir Med. 2017;11:119–128.
- Laubach VE, Sharma AK. Mechanisms of lung ischemia-reperfusion injury. Curr Opin Organ Transplant. 2016;21:246–252.
- Yu AY, Frid MG, Shimoda LA, et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol. 1998;275:L818–L826.
- Carter YM, Gelman AE, Kreisel D. Pathogenesis, management, and consequences of primary graft dysfunction. Semin Thorac Cardiovasc Surg. 2008;20:165–172.
- Fiser SM, Tribble CG, Long SM, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg. 2001;121:1069–1075.
- Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med. 2012;38:1588–1598.
- Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122:2711–2719.
- Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950–2954.
- Gallinat A, Paul A, Efferz P, et al. Hypothermic reconditioning of porcine kidney grafts by short-term preimplantation machine perfusion. Transplantation. 2012;93:787–793.
- Goto T, Ishizaka A, Kobayashi F, et al. Importance of tumor necrosis factor-alpha cleavage process in post-transplantation lung injury in rats. Am J Respir Crit Care Med. 2004;170:1239–1246.
- Saito T, Liu M, Binnie M, et al. Distinct expression patterns of alveolar “ alarmins” in subtypes of chronic lung allograft dysfunction”. Am J Transplant. 2014;14:1425–1432.
- Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest. 2011;140:502–508.
- Verleden SE, Vandermeulen E, Ruttens D, et al. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Semin Respir Crit Care Med. 2013;34:352–360.
- Li G, Liang X, Lotze MT. HMGB1: the central cytokine for all lymphoid cells. Front Immunol. 2013;4:68.
- Nakagiri T, Inoue M, Morii E, et al. Local IL-17 production and a decrease in peripheral blood regulatory T Cells in an animal model of bronchiolitis obliterans. Transplantation. 2010;89:1312–1319.
- Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30:735–742.
- Sato M, Hwang DM, Waddell TK, et al. Progression pattern of restrictive allograft syndrome after lung transplantation. J Heart Lung Transplant. 2013;32:23–30.
- Ueno H, Matsuda T, Hashimoto S, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med. 2004;170:1310–1316.
- Sharma AK, LaPar DJ, Zhao Y, et al. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med. 2011;183:1539–1549.
- Sharma AK, LaPar DJ, Stone ML, Z, et al. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury: RAGE and NKT Cells inlung reperfusion injury. Am J Transplant. 2013;13:2255–2267.
- Hamilton BCS, Kukreja J, Ware LB, et al. Protein biomarkers associated with primary graft dysfunction following lung transplantation. Am J Physiol Lung Cell Mol Physiol. 2017;312:L531–L541.
- Moreno I, Vicente R, Ramos F, et al. Determination of Interleukin-6 in lung transplantation: association with primary graft dysfunction. Transplant Proc. 2007;39:2425–2426.